TREE NEWS update: China’s overall medical service prices rose 26.0% cumulatively between 2018 and 2025, an average annual increase of about 3.4%, the National Healthcare Security Administration said. The growth rate was below the average annual increase in per capita disposable income over the same period. Price adjustments have been mixed, with examination and testing fees declining while the value of technical labor is further highlighted, keeping patients’ overall medical burden stable.
China’s Medical Service Prices Rose 26% Cumulative from 2018 to 2025
The significance here is structural rather than headline-level: Beijing is signalling that price reform in medical services is being managed as a deliberate rebalancing, cutting examination and testing fees while lifting the technical labor component, all while keeping the aggregate burden stable and below income growth. That mix matters for anyone exposed to China's diagnostics and testing supply chain, where volume and pricing pressure may persist even as overall service spending rises. The open question is whether this calibration — technical labor up, testing down, burden flat — continues as the stated pattern in future adjustments.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.